… in small animal models, non-human primates, and human volunteers. In this study, … non-human
primates received a prime-boost intramuscular vaccination with 4 µg of mRNA vaccine …

To contain the coronavirus disease 2019 (COVID-19) pandemic, a safe and effective
vaccine against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is …

… mRNA-1325 and mRNA-1893 vaccination and reported that mRNA-1893 generated … ZIKV
challenge in non-human primates. In-depth characterization of these vaccines indicated that …

… Messenger RNA technology allows versatile vaccine antigen design and highly scalable, …
, RNA vaccines are highly suited to rapid development and pandemic supply 12, 13 . RNA …

… Overall, 8 μg CVnCoV vaccination induced the lowest number of viral RNA copies in the
upper respiratory tract, where median values of 2.9 x 10 6 cp/ml in nasal swabs, respectively, …

… the vaccine was capable of inducing strong immune responses in a nonhuman primate
model that more closely resembles humans in the immune response to vaccination. Three …

… if the vaccine was capable of inducing strong immune responses in a nonhuman primate
model that more closely resembles humans in the immune response to vaccination. Three …

… of a model messenger RNA vaccine labelled with the probe. After intramuscular administration
of the vaccine to the monkeys, we observed the dynamics of the mRNA vaccine at the …

… shown, and changes in protein and RNA expression patterns identified, … vaccine research
in nonhuman primates was in some ways a successful forerunner to the SARS-CoV-2 vaccine …

… COVID-19 vaccines. Here we tested a novel COVID-19 self-amplifying … RNA vaccine in
a nonhuman primate model. We found that various doses of the vaccine and different vaccine …